Freenome rais­es $254M for ear­ly can­cer de­tec­tion tests

Freenome has raised an ad­di­tion­al $254 mil­lion in pri­vate fund­ing, led by Roche, as the com­pa­ny nears piv­otal re­sults for its blood-based can­cer test. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.